INTRODUCTION
============

The hepatitis B virus infection can cause severe chronic liver disease, and is a public health problem in several countries^[@B31]^. In Brazil, approximately 14,000 cases of hepatitis B virus infection are reported every year and 120,343 cases were reported from 1999 to 2011^[@B03]^.

The hepatitis B virus can be transmitted through percutaneous or mucosal exposure to infected blood or body fluids, and health-care personnel are at risk of acquiring the disease from needle stick injuries or other types of occupational exposures^[@B09]^. This risk may be higher during the professional training period^[@B11],[@B14],[@B24],[@B25]^. Therefore, the hepatitis B vaccination is strongly recommended for health-care personnel, including medical students and students of other health professions, and these individuals should perform the hepatitis B surface antibody (anti-HBs) testing 1-2 months after vaccination to evaluate the protective antibody response to the vaccine^[@B04],[@B11]^.

In Brazil, students currently entering medical school were born before the implementation of universal hepatitis B vaccination of infants in 1998^[@B05]^. Vaccination of adolescents was recommended in 2001^[@B05]^, but this group is difficult to be reached by immunization programs, and studies have reported low vaccination coverage among Brazilian adolescents^[@B06],[@B27]^. Consequently, students may enter medical school still unvaccinated against hepatitis B, and immunization programs at medical schools could contribute to vaccination of susceptible students. However, not all Brazilian medical schools have implemented such programs or student vaccination requirements. Therefore, it cannot be assumed *a priori* that most medical students are properly protected against hepatitis B. In fact, inadequate hepatitis B vaccination coverage has been observed among medical students and students of other health professions in Brazil^[@B07],[@B08],[@B12],[@B29]^.

Information on vaccination coverage among medical students regarding the vaccines that are recommended for health-care personnel can contribute to the implementation of appropriate immunization efforts at medical schools. In this context, the aim of this study was to determine the hepatitis B vaccination coverage among medical students at a public university in Brazil, and their compliance with the postvaccination serologic testing recommendations.

MATERIALS AND METHODS
=====================

This cross-sectional study was conducted at the *Universidade Federal do Estado do Rio de Janeiro* Medical School. This medical school is one of the three public medical schools located in the city of Rio de Janeiro, Brazil, and offers a six-year course in medicine. Approximately one hundred and forty students are admitted each year. Students begin to have contact with patients and to perform some procedures, with risk of occupational exposures, in the second year of medical school. All medical students enrolled at this school in the second semester of 2010 were eligible to participate in this study. The invitation to participate was made during mandatory classes for students on different occasions.

A self-administered questionnaire was used to collect the following data: age, sex, and the student\'s current year in medical school; whether the student had been vaccinated against hepatitis B or not; the number of vaccine doses received by the student; whether the student had performed the anti-HBs testing after vaccination, and the approximate interval between the last vaccine dose and the anti-HBs testing.

In the present study, students were considered "vaccinated" against hepatitis B when they had received three or more doses of the vaccine, and were considered "unvaccinated" when they had not received the vaccine or had received only one or two vaccine doses. Vaccination status was considered "unknown" when students reported that they did not know if they had received the vaccine or they did not know the number of doses received.

The data were entered into an electronic database using double data entry, and a descriptive analysis was performed for all study variables. The 95% confidence interval was calculated for the frequency of students who were "vaccinated" against hepatitis B. Vaccination status was compared across gender using the chi-square test. Analyses were performed with Epi Info (version 3.5.3 - 2011).

This study was approved by the ethics review committee of the Gaffrée e Guinle University Hospital at the *Universidade Federal do Estado do Rio de Janeiro*, and all students signed an informed consent before entering the study.

RESULTS
=======

In the second half of 2010, 858 students were enrolled at the *Universidade Federal do Estado do Rio de Janeiro* Medical School, and 675 (78.7%) responded to the survey questionnaire. Response rate ranged from 63.0% among sixth-year students to 92.4% among fourth-year students ([Table 1](#t01){ref-type="table"}). The mean age of the students was 22.8 years ± 2.8 (range: 17 to 49 years): 59.7% were female students, and 40.3% were male students. Information on age was missing for eight students.

Table 1Response rate and hepatitis B vaccination status according to year of medical school among Brazilian medical studentsYear of medical schoolResponse rate (n = 858)Vaccination status (n = 675)VaccinatedUnknownUnvaccinatedn/N%n%n%n%First131/14987.93426.05239.74534.4Second102/14570.33130.43635.33534.3Third114/14777.65850.91916.73732.5Fourth146/15892.48155.51510.35034.2Fifth97/12478.26668.088.22323.7Sixth85/13563.06070.622.42327.1Total675/85878.733048.913219.621331.6

Of the total of 675 students, 330 students (48.9%; 95% CI: 45.1% to 52.7%) were vaccinated against hepatitis B (received ≥ 3 doses of the vaccine), 213 (31.6%) were unvaccinated (received zero, one or two doses of the vaccine), and 132 students (19.6%) did not know their vaccination status (did not know if they had received the vaccine or did not know the number of vaccine doses received). Among the 213 students who were considered unvaccinated against hepatitis B, 80 students (37.6%) did not receive any dose of the vaccine, 51 students (23.9%) received one dose, and 82 students (38.5%) received two doses.

The ≥ 3-dose hepatitis B vaccination coverage increased from 26.0% among first-year students to 70.6% among sixth-year students. On the other hand, the prevalence of unknown vaccination status decreased from 39.7% among first-year students to 2.4% among sixth-year students. The frequency of unvaccinated students ranged from 23.7% among fifth-year students to 34.4% among first-year students ([Table 1](#t01){ref-type="table"}).

Among male students (n = 272), 47.8% were vaccinated against hepatitis B, 32.4% were not, and 19.9% did not know their vaccination status. Among female students (n = 403), 49.6% were vaccinated, 31.0% were not, and 19.4% did not know their vaccination status (*p* = 0.89).

Of the total of 330 fully vaccinated students, 115 students (34.8%) performed the anti-HBs testing after vaccination. Additionally, 15 students who had received one or two doses of the vaccine, and eight students who did not know the number of doses of the vaccine they had received also performed the anti-HBs testing after vaccination. Accordingly, a total of 138 students did the postvaccination serologic testing. Most students performed the anti-HBs testing one or more years after vaccination or did not know this interval ([Table 2](#t02){ref-type="table"}).

Table 2Approximate interval between the last dose of the hepatitis B vaccine and the anti-HBs testing among Brazilian medical students (n = 138)Approximate interval between the last dose of the vaccine and the anti-HBs testingStudentsn%\< 1 year2316.71-4 years3424.6≥ 5 years1913.8Unknown5842.0Missing42.9

DISCUSSION
==========

In this study we observed a low uptake of the hepatitis B vaccine among a group of Brazilian medical students since 31.6% of them were not fully vaccinated. The proportion of unvaccinated students may have even been underestimated because approximately 20% of the students did not know their vaccination status, and some of these students could be unvaccinated. In addition and perhaps more importantly, among students attending the final year of medical school, hepatitis B vaccination coverage was only 70.6%, and in this group 2.4% of the students did not know their vaccination status.

Few studies have investigated the hepatitis B vaccination coverage among medical students in Brazil^[@B01],[@B07],[@B12],[@B24]^. One study reported a vaccination coverage of 71.3% among fifth-year medical students^[@B12]^ and this result was similar to that observed among our students who were in the same year of medical school (68.0%). In another study, a higher vaccination coverage and of 86.8% was observed among second- to sixth-year medical students^[@B24]^. At a medical school in the state of Santa Catarina, Brazil only 53.8% of the students were vaccinated against hepatitis B, but in this study the number of vaccine doses was not determined, and the vaccination status was unknown for approximately 43% of the students^[@B01]^.

Other studies conducted in Brazil assessed the hepatitis B vaccination coverage among different groups of health-care personnel, with varying results. As among our students, vaccine uptake was suboptimal in some of these groups^[@B02],[@B08],[@B17],[@B28]--[@B30]^. Vaccination coverage of less than 80% has been reported among physicians in two Brazilian cities^[@B17],[@B28]^, residents in pediatrics^[@B30]^, dental students^[@B08],[@B29]^, and health-care workers in the city of Belo Horizonte^[@B02]^. Among health-care students, including medical students, who were exposed to biological material in São Paulo-Brazil, only 77.1% of them had received three or more doses of the vaccine^[@B18]^. On the other hand, vaccination coverage of more than 90% was observed among dentists^[@B16]^ and physicians^[@B02],[@B15]^ in some Brazilian cities. However, one must be careful to compare the results of these studies because different methods were used to assess the vaccination status (self-reported vaccination status or vaccination records), and in some studies it is unclear whether vaccinated individuals were only those who had received the 3-dose vaccine series or were individuals who had received at least one dose of the vaccine. In other countries, including the US, optimal hepatitis B vaccination coverage among health-care personnel has not been achieved either^[@B22]^.

Interestingly, we observed that hepatitis B vaccination coverage increased progressively from 26.0% among first-year students to 70.6% among sixth-year students while the prevalence of unknown vaccination status decreased from 39.7% to 2.4%. Since this study was not prospective and we did not investigate when students were vaccinated, whether before or during the medical course, we cannot explain these findings with certainty. Perhaps, students attending different years of the medical course had already different vaccination status when they were admitted to medical school. However, during the medical course students have several opportunities to learn about the importance of being vaccinated against hepatitis B and of knowing their vaccination status. The acquisition of this knowledge might have contributed to a higher vaccination coverage and a lower prevalence of unknown vaccination status among students attending the last years of the medical course. Nevertheless, in each year of this medical course, approximately a quarter to a third of the students had not received the 3-dose hepatitis B vaccine series.

In Brazil, the hepatitis B vaccine is available free of charge to health-care personal, including medical students, at a large network of health-care facilities. In the present study, we did not investigate the reasons that could eventually explain why students were not vaccinated. However, the medical school where this study was conducted does not have a student immunization program or vaccination requirements, and this might have contributed to the low hepatitis B vaccine uptake among our study group. In this regard, a higher hepatitis B vaccination coverage was reported among Brazilian medical students to whom an immunization program was offered at their medical school^[@B24]^.

Exposure to blood or body fluids potentially contaminated with hepatitis B virus is common among medical students^[@B12],[@B14],[@B18],[@B24]--[@B26]^. Moreover, in Brazil, the number of confirmed cases of hepatitis B infection is higher among young adults than among other age groups, and most cases of the disease are probably acquired through sexual contact^[@B03]^. The majority of medical students are young adults, and thus unvaccinated medical students may be at risk of acquiring the disease not only through occupational exposures but also by sexual contact.

In the present study, only 34.8% of the vaccinated students performed the anti-HBs testing after vaccination to determine their antibody response to the vaccine. However, based on this result we cannot conclude whether or not the students complied with the postvaccination serologic testing recommendations for health-care personnel because we did not investigate when students were vaccinated, and the anti-HBs testing was not mandatory for those students vaccinated in the past, before entering medical school^[@B11]^. In fact, different recommendations would have been acceptable for students vaccinated before entering medical school: not to perform the anti-HBs testing unless they were exposed to blood or body fluids^[@B11]^ or to perform the testing and eventually administer a booster dose of the vaccine to those with anti-HBs concentrations of less than 10 mIU/mL^[@B04],[@B10]^. On the other hand, students vaccinated during the medical course should have performed the anti-HBs testing 1-2 months after the last dose of the hepatitis B vaccine series^[@B04],[@B11]^. Nevertheless, we can conclude that the response to the vaccine was unknown for most of the vaccinated students, and this can be an issue in some circumstances. When the response to the vaccine is unknown, the management of health-care personnel potentially exposed to hepatitis B virus is more complex, and in this context the anti-HBs testing should be performed immediately. However, in some settings in Brazil, the anti-HBs testing or its results may not be readily available. Other studies conducted in Brazil also reported that a significant proportion (approximately 32% to 48%) of health-care personnel who were vaccinated against hepatitis B did not perform the postvaccination serologic testing^[@B15],[@B24],[@B28]^.

In addition, most students performed the anti-HBs testing one or more years after the last dose of the vaccine or did not know how long after vaccination the testing had been performed. The anti-HBs testing performed years after vaccination is not adequate for evaluating the response to the vaccine because anti-HBs concentrations decline over time. However, individuals who responded to the 3-dose vaccine series remain protected even if their anti-HBs concentration declines to below 10 mIU/mL due to immune memory^[@B23]^. In this respect, among health-care students in Taiwan, who were vaccinated during infancy with a recombinant hepatitis B vaccine, a study reported that after 16 years only 33% had protective levels of anti-HBs, but 95.9% of the anti-HBs negative students achieved protective levels of anti-HBs after a booster dose of the vaccine, indicating the presence of immune memory^[@B20]^. Perhaps, in the present study, students performed the anti-HBs testing years after vaccination because they were vaccinated in the past and desire to know whether they were protected against hepatitis B or not. In this context, to perform the anti-HBs testing is an acceptable option as far as the test results are correctly interpreted and the students are properly counseled.

In Brazil, universal hepatitis B vaccination of infants was implemented in 1998, and vaccination of adolescents younger than 20 years of age was recommended in 2001^[@B05]^. A study conducted among Brazilian medical students in 2009 reported that approximately 60% of the students were vaccinated against hepatitis B before entering medical school^[@B24]^. In the future, more students will possibly enter medical school already vaccinated against hepatitis B and medical schools will have to decide whether to recommend the anti-HBs testing for all students or only for those who have an occupational exposure.

This study has some limitations. Assessment of vaccine uptake was based on student self-reported vaccination status, and misclassifications might have occurred. However, the use of vaccination records to assess vaccination status can also lead to misclassification of individuals with missing vaccination records. Among some groups, missing or unavailable vaccination records are not uncommon^[@B15],[@B30]^, and a study conducted among Brazilian nursing and medical students reported that, after several attempts, only 11% of the students provided their vaccination cards^[@B07]^. Furthermore, we could have had more accurate and complete information on the postvaccination serologic testing if we had determined when students were vaccinated, whether at medical school or before, and if we had reviewed the laboratory reports for the anti-HBs testing. However, laboratory reports are not easily available. Some fifth- and sixth-year students answered the study questionnaire later than the other students. Consequently, they had more time to clarify their vaccination status, and to complete their hepatitis B vaccination schedule, perhaps influenced by their knowledge about the survey. This might have contributed to increase the vaccination coverage in this group. On the other hand, there are few studies reporting on hepatitis B vaccination coverage among Brazilian medical students, and the present study, despite its limitations, can provide additional information regarding health-care students compliance with the recommended vaccines in Brazil.

In conclusion, in the present study we found a low uptake of the hepatitis B vaccine among a group of Brazilian medical students, despite the wide availability of the vaccine. In addition, most vaccinated students did not perform the postvaccination serologic testing and thus, their response to the vaccine was unknown. It is well recognized that medical students have a high risk of being exposed to blood and body fluids potentially contaminated with hepatitis B virus, and hepatitis B vaccination is mandatory or recommended for these students in several countries^[@B11],[@B13],[@B19],[@B21]^ . Accordingly, this medical school should urgently consider to implement a comprehensive student immunization program against hepatitis B, which may contribute to improve students\' adherence to vaccination. This program should be offered early in the medical course and provide not only vaccination but also screening and follow up. Furthermore, education on prevention and management of occupational exposures should be also provided to these students, and counseling should be immediately available in case of exposure. Finally, continuous surveillance of hepatitis B vaccination coverage among medical students should be undertaken in Brazil, especially at those medical schools which do not have student vaccination requirements.
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